April 6, 2007 - Hospira Inc. introduced a new wireless platform for its medication infusion devices that incorporates leading-edge authentication standards and encryption protocols to assist hospitals in securely transferring data and complying with patient confidentiality regulations. The new technology also provides the first three- in-one wireless multi-band module for an infusion system, enabling hospitals to select any of three frequency modes for communication.

The platform's expanded security options help ensure only designated, approved hospital staff access clinical data transmitted between the devices and hospital information technology systems as part of the intravenous (I.V.) medication administration process. This can help healthcare providers more readily comply with patient confidentiality regulations, such as the Health Insurance Portability and Accountability Act, or HIPAA, in securing patient data against inadvertent release.

Most wireless products, such as mobile phones, pagers and other medical devices, communicate via the 802.11 "b" or "g" modes on the 2.4 GHz band. With Hospira's new platform, hospitals can choose to operate the company's infusion devices in the "b" or "g" modes, as well as the less frequently used "a" (5 GHz band) wireless mode, to help ensure clear, consistent data transmission.

Hospira is currently offering this new capability with the Plum A (R) single-channel infusion device and will be adding it to its Plum A (R)3 triple-channel device, LifeCare PCA(R) patient-controlled analgesia system and Symbiq(TM) infusion system later this year. The devices work in conjunction with the Hospira MedNet(R) system, a scaleable and upgradeable patient safety platform.


Related Content

News | Radiopharmaceuticals and Tracers

Jan. 29, 2026 — The American Society for Radiation Oncology (ASTRO) has launched a national program creating Authorized ...

Time January 30, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
News | Radiology Imaging

Jan. 21, 2026 — Cathpax, a spin-off of the Lemer Pax group that designs, develops and commercializes team-wide, full ...

Time January 22, 2026
arrow
News | Radiation Therapy

Jan. 16, 2026 — Elekta has announced that its Elekta Evo* CT-Linac has received 510(k) clearance from the U.S. Food and ...

Time January 16, 2026
arrow
News | Radiopharmaceuticals and Tracers

Dec. 11, 2025 — Telix Pharmaceuticals Ltd. has announced a strategic clinical collaboration with Varian, a Siemens ...

Time December 11, 2025
arrow
News | Women's Health

Nov. 3, 2025 — —A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 ...

Time November 04, 2025
arrow
Feature | Kyle Hardner

Radiotherapy contributes to about 40% of all cancer cures but still lags behind systemic therapy in funding and ...

Time October 21, 2025
arrow
News | Radiation Oncology

Sept. 02, 2025 — Alpha Tau Medical Ltd., the developer of the alpha-radiation cancer therapy Alpha DaRT has announced ...

Time September 05, 2025
arrow
News | Radiation Oncology

May 2, 2025 — GE HealthCare has announced an intended expansion of its radiation oncology portfolio as well as the ...

Time May 03, 2025
arrow
News | Radiology Education

April 21, 2025 — On June 20, the American Society of Radiologic Technologists (ASRT) will award Life Member status to ...

Time April 21, 2025
arrow
Subscribe Now